Most Active Healthtech Investors in Boston 2026

15 firms writing Healthtech checks in Boston, led by Boston Millennia Partners, Excelerate Health Ventures.

Healthtech in Boston accounts for 13 tracked companies with verified cap-table data, 13 of which disclose round sizes totalling $2.4B. The median disclosed raise is $115M, and the largest is WHOOP at $575M, ahead of Reify Health ($477M) and Eight Sleep ($260M).

The names that recur most often on these healthtech cap tables are General Catalyst (3 companies), Collaborative Fund (1 company), 2PointZero Group (1 company), Qatar Investment Authority (QIA) (1 company), Mubadala Investment Company (1 company), Abbott (1 company). By latest disclosed round, the market skews Series C (4), Series D (3), Series B (3), Series G (1).

Best funded Healthtech in Boston companies

  1. WHOOP — $575M (latest: Series G)
  2. Reify Health — $477M (latest: Series D)
  3. Eight Sleep — $260M (latest: Series D)
  4. PathAI — $255M (latest: Series C)
  5. Overjet — $130M (latest: Series C)
  6. Elucid — $121M (latest: Series C)
  7. IntelyCare — $115M (latest: Growth)
  8. Cohere Health — $100M (latest: Series C)
  9. Eleanor Health — $80M (latest: Series D)
  10. Assured Allies — $78M (latest: Series B)
  11. PhaseV — $65M (latest: Series A)
  12. Ketryx — $55M (latest: Series B)
  13. Labviva — $55M (latest: Series B)

Sector × city funding reports (20)

All research · Investor directory · Company funding database · Fundraising library